Today: 7 February 2026
Subscribe
Browse Category

Investment News News 31 January 2026 - 1 February 2026

Coherent stock slips into earnings week as Morgan Stanley lifts target on COHR

Coherent stock slips into earnings week as Morgan Stanley lifts target on COHR

Coherent shares closed Friday down 1.7% at $212.18, slipping to $211.84 after hours. Morgan Stanley raised its price target to $190 but kept an equal-weight rating ahead of Coherent's Feb. 4 earnings. The stock swung between $210.48 and $237.18 during the session. Investors await earnings from Coherent and Lumentum for signals on datacenter demand.
1 February 2026
·····
MediaTek stock price slips into weekend; Feb 4 earnings call is the next test

MediaTek stock price slips into weekend; Feb 4 earnings call is the next test

MediaTek shares fell 1.12% to T$1,760 at Friday’s close ahead of its Feb. 4 earnings report. Taiwan’s benchmark index dropped 1.45% to 32,063.75, with turnover near NT$907 billion. Investors await MediaTek’s guidance on smartphone chip demand and AI projects. Markets in Taiwan are now closed for the weekend.
1 February 2026
·····
Intel stock price drops to $46.47 as Vanguard stake filing lands; traders eye Feb 6 jobs report

Intel stock price drops to $46.47 as Vanguard stake filing lands; traders eye Feb 6 jobs report

Intel shares fell 4.4% to $46.47 Friday, with trading volume near 115 million. Vanguard disclosed an 8.11% stake in a new filing. The drop followed weaker-than-expected earnings and ongoing supply issues. Wall Street indexes also declined after President Trump nominated Kevin Warsh for Fed chair and inflation data came in above forecasts.
1 February 2026
···
Nvidia stock price in focus after Huang vows a “huge” OpenAI investment ahead of Monday trade

Nvidia stock price in focus after Huang vows a “huge” OpenAI investment ahead of Monday trade

Nvidia shares fell 0.7% to $191.13 Friday after CEO Jensen Huang said the company will make its largest-ever investment in OpenAI, but not $100 billion. A Vanguard filing showed it owned 9.32% of Nvidia as of Dec. 31. The OpenAI deal is being reconsidered, according to the Wall Street Journal. Nvidia reports quarterly results Feb. 25.
1 February 2026
·····
Salesforce stock heads into Monday after software rout as AI fears hang over CRM shares

Salesforce stock heads into Monday after software rout as AI fears hang over CRM shares

Salesforce shares closed Friday at $212.29, down 0.8%, after plunging 7.1% Thursday amid a broad software selloff. Concerns over AI’s impact on software subscription models weighed on the sector. Investors are awaiting U.S. jobs data on Feb. 6 and Salesforce’s earnings later this month. Wall Street indexes also fell Friday on economic and political developments.
31 January 2026
········
China Mobile Class A stock price: 600941 heads into Monday after China PMI shock and a UBS downgrade

China Mobile Class A stock price: 600941 heads into Monday after China PMI shock and a UBS downgrade

China Mobile’s Shanghai shares fell 0.6% to 96.38 yuan Friday, underperforming amid a broader market downturn and weak January PMI data. UBS downgraded the company’s Hong Kong shares, citing pressure on core telecom and cloud services. China Telecom rose 1.0%, while China Unicom slipped 0.8%. China Mobile’s next earnings report is scheduled for March 27.
31 January 2026
·····
Shell share price slips as buyback wraps up; earnings on deck next week

Shell share price slips as buyback wraps up; earnings on deck next week

Shell shares slipped 0.1% to 2,794 pence in London on Friday, easing after Thursday’s rally. The company bought back over 1.3 million shares in London and Amsterdam for cancellation on Jan. 30. Brent crude pulled back to $70.69 a barrel as traders weighed U.S.-Iran diplomacy. Shell will report fourth-quarter results and an interim dividend on Feb. 5.
31 January 2026
····
Novo Nordisk Class B stock price: Wegovy pill scripts hit 26,000 as earnings week approaches

Novo Nordisk Class B stock price: Wegovy pill scripts hit 26,000 as earnings week approaches

Novo Nordisk Class B shares closed down 0.23% at 369.55 Danish kroner Friday, capping a 7.9% slide over five sessions. U.S. prescriptions for oral Wegovy reached 26,109 in the week ending Jan. 23, after 3,071 in the first four days post-launch. The company faces rising competition in China and awaits EU approval for its MASH drug. Quarterly results and 2026 outlook are due Feb. 4.
31 January 2026
·····
Morgan Stanley stock price: $6 million insider sale and Trump’s Fed pick loom over Monday trade

Morgan Stanley stock price: $6 million insider sale and Trump’s Fed pick loom over Monday trade

Morgan Stanley co-president Daniel Simkowitz sold 32,968 shares for about $6.0 million, leaving him with 357,342 shares, a regulatory filing showed Friday. Morgan Stanley stock closed up 0.2% at $182.80. The sale comes as markets react to Trump’s pick of Kevin Warsh for Fed chair and rising U.S. producer prices.
31 January 2026
·····
AstraZeneca share price: $18.5 billion China obesity-drug deal puts AZN stock in focus for Monday

AstraZeneca share price: $18.5 billion China obesity-drug deal puts AZN stock in focus for Monday

AstraZeneca agreed to license obesity drug candidates from CSPC Pharmaceutical in a deal worth up to $18.5 billion, paying $1.2 billion upfront. AstraZeneca shares rose 0.65% in London, while CSPC shares fell nearly 12% in Hong Kong. The deal gives AstraZeneca rights outside Greater China and includes a once-monthly GLP-1/GIP agonist entering Phase I trials. AstraZeneca will also delist its ADS from Nasdaq and move to the NYSE.
31 January 2026
···
1 … 21 22 23 24 25 … 215

Stock Market Today

Meta stock faces an AI split: ad gains vs a $135 billion bill

Meta stock faces an AI split: ad gains vs a $135 billion bill

7 February 2026
Meta shares dropped 1.3% to $661.46 on Friday after the company projected 2026 capital spending of up to $135 billion, raising investor concerns over cash flow. Meta reported Q4 revenue of $59.89 billion, up 24% year-over-year, with ad impressions rising 18%. Analysts remain divided on whether AI-driven ad gains can offset the steep spending ramp.
Go toTop